This week, Congress remains in session and the Administration remains hard at work on the regulatory side, publishing the Medicare Physician Fee Schedule for 2019 last Thursday in addition to the CY 2019 Changes to End-Stage Renal Disease Prospective Payment System. Comments on both proposed rules are due by September 10, 2018.

The Administration’s drug pricing plan and request for information’s deadline for comments is today. It sets up the Administration to work on drug pricing issues this fall, but the question remains whether Congress will take up anything meaningful. The Administration’s recent focus on drug pricing suggests they will look for steps they can take unilaterally as well as through Congress.